Sour Cherry Seed Extract Topical Formulation for Osteoarthritis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis, such as analgesics and biotherapeutic drugs, fail to effectively address the underlying pathomechanisms of the disease, including inflammation and cartilage destruction, and are often costly and associated with severe side effects.
Innovation Solution
A topical biotherapeutic composition comprising a combination of sour cherry seed extract (SCE) and sour cherry seed oil (SCO) is developed, which induces heme oxygenase-1 (HO-1) activity, thereby reducing joint pain, inflammatory cytokine production, and oxidative stress, and inhibiting disease-associated inflammatory mediator production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional analgesics and biotherapeutic drugs are used to treat osteoarthritis, then pain management and inflammatory control are achieved, but the underlying pathomechanisms remain unaddressed and severe side effects occur
Solution Approach 1:
The patent replaces expensive, complex biotherapeutic drugs with a simple, natural topical formulation derived from sour cherry seeds. This natural formulation achieves therapeutic effects without the severe side effects associated with conventional drugs, effectively using a simple, accessible substance to replace complex pharmaceutical interventions
Solution Approach 2:
The patent introduces HO-1 (heme oxygenase-1) as a mediator that naturally regulates inflammatory responses. The sour cherry seed formulation works by inducing HO-1 expression, which then acts as an endogenous mediator to control inflammation and protect against tissue damage, avoiding the need for direct administration of potent pharmaceutical agents
2Reliability
If genetically engineered cytokine inhibitors are administered to OA patients, then inflammatory cytokine activity is reduced, but structural deterioration continues and severe side effects including cancer and immune impairment occur
Solution Approach 1:
The patent converts the body's own inflammatory response into a beneficial protective mechanism by inducing HO-1 expression. Instead of suppressing inflammation with potent inhibitors that cause severe side effects, the formulation harnesses the body's natural anti-inflammatory pathways through HO-1, which produces protective molecules like carbon monoxide and bilirubin that actively protect tissues
Solution Approach 2:
The patent enables the body to self-regulate inflammation through induced HO-1 expression. The sour cherry seed formulation triggers the body's own protective mechanisms, allowing endogenous cells to produce anti-inflammatory mediators and protect against tissue damage without requiring continuous external administration of potent pharmaceutical agents
3Reliability
If corticosteroids and non-steroidal anti-inflammatories are used to control inflammation, then inflammatory symptoms are suppressed, but severe toxicity occurs particularly over extended time periods
Solution Approach 1:
The patent replaces toxic corticosteroids and NSAIDs with a safe, natural topical formulation from sour cherry seeds. This formulation provides sustained anti-inflammatory effects through HO-1 induction without the cumulative toxicity of conventional drugs, using simple natural compounds to replace potent but harmful pharmaceuticals
Solution Approach 2:
The patent changes the mechanism of anti-inflammatory action from direct suppression of inflammatory pathways (which causes toxicity) to induction of protective HO-1 expression. This parameter change in the therapeutic approach shifts from inhibiting inflammation to actively protecting tissues, achieving anti-inflammatory effects without toxic side effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SCE/SCO composition significantly reduces joint pain, decreases peripheral blood c-reactive protein levels, increases leukocyte HO-1 expression, and inhibits the production of inflammatory cytokines by CD3+ T lymphocytes, effectively addressing the underlying inflammatory processes in osteoarthritis.
Implementation Method 1
The SCE/SCO composition systemically increases the activity of HO-1, a major physiological protectant against oxidative stress
Implementation Method 2
Oxidative stress, created by this degradative process, promotes emergence of senescent osteoarthritic osteoblasts
Implementation Method 3
The production of inflammatory cytokines by activated CD3+ T lymphocytes offers an excellent 'choke point' for intervention in OA pathogenesis
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A biotherapeutic anti-inflammatory composition, its method of manufacture and method of treatment of various diseases, the composition having an efficacious amount of solid sour cherry seed extract and sour cherry seed oil sufficient to inhibit production of disease-associated inflammatory cytokines by CD3+ T lymphocytes in a vertebrate mammal.